X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (10) 10
male (7) 7
female (6) 6
aged (5) 5
middle aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
leukemia (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
patients (4) 4
rituximab (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cd20 antigen (3) 3
chemotherapy (3) 3
chronic lymphatic leukemia (3) 3
chronic lymphocytic-leukemia (3) 3
cll (3) 3
fludarabine (3) 3
in-vitro (3) 3
initial therapy (3) 3
kinases (3) 3
lymphatic leukemia (3) 3
open-label (3) 3
proteins (3) 3
treatment outcome (3) 3
adult (2) 2
analysis (2) 2
animals (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
apoptosis (2) 2
b-cell lymphoma (2) 2
biology (2) 2
chlorambucil - administration & dosage (2) 2
chronic lymphocytic leukemia (2) 2
clinical trials (2) 2
deuteration (2) 2
deuterierung (2) 2
deuterium (2) 2
disease (2) 2
disease-free survival (2) 2
drug therapy (2) 2
fish odor (2) 2
genomic aberrations (2) 2
hematology (2) 2
ibrutinib (2) 2
immunoglobulins (2) 2
infections (2) 2
lipids (2) 2
lymphocytes b (2) 2
metabolic disorder (2) 2
mice (2) 2
minimal residual disease (2) 2
neutropenia (2) 2
nmr spectroscopy (2) 2
nuclear magnetic resonance spectroscopy (2) 2
nuclear magnetic resonance, biomolecular - methods (2) 2
nuclear magnetic resonance--nmr (2) 2
obinutuzumab (2) 2
oncology (2) 2
osteoclasts - pathology (2) 2
perdeuterated proteins (2) 2
progression-free (2) 2
prospective studies (2) 2
remission induction (2) 2
rheumatology (2) 2
risk factors (2) 2
rituximab - administration & dosage (2) 2
solvents (2) 2
spectrum analysis (2) 2
spinning (2) 2
survival (2) 2
trimethylaminuria (2) 2
17p deletion (1) 1
1st-line therapy (1) 1
abnormal karyotype (1) 1
adolescent (1) 1
aggregates (1) 1
amide (1) 1
amides (1) 1
amyloid fibrils (1) 1
anti-cd20 antibody (1) 1
anti-cd20 monoclonal-antibody (1) 1
anti-citrullinated protein antibodies - blood (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibody-dependent cell-mediated cytotoxicity (1) 1
antigens (1) 1
antigens, cd20 - immunology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
apoptosis - genetics (1) 1
arrest-specific gene-6 (1) 1
arthritis (1) 1
arthritis, experimental - complications (1) 1
arthritis, experimental - enzymology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 12, pp. 1101 - 1110
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1215 - 1228
Journal Article
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 2, pp. 208 - 215
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2014, Volume 73, Issue 4, pp. 771 - 779
Objective To test whether the tyrosine kinase Tyro3 affects arthritis. Tyro3, the ligand of growth arrest–specific protein 6 (GAS6) is a receptor tyrosine... 
RHEUMATOID-ARTHRITIS | CELLS | AXL | ARREST-SPECIFIC GENE-6 | LIGAND | DIFFERENTIATION | RHEUMATOLOGY | GAS6 | IDENTIFICATION | EXPRESSION | FIBROBLASTS | Humans | Receptor Protein-Tyrosine Kinases - physiology | Synovial Membrane - pathology | Arthritis, Rheumatoid - complications | Osteoporosis - etiology | Arthritis, Experimental - metabolism | Dose-Response Relationship, Drug | Arthritis, Rheumatoid - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Osteoporosis - enzymology | Cell Differentiation - physiology | Hyperplasia - prevention & control | Osteoclasts - pathology | Receptor Protein-Tyrosine Kinases - deficiency | Osteoporosis - prevention & control | Mice, Inbred C57BL | Cells, Cultured | Arthritis, Rheumatoid - enzymology | Arthritis, Experimental - complications | Gene Knockout Techniques | Synovial Membrane - metabolism | Hyperplasia - etiology | Mice, Knockout | Animals | Receptor Protein-Tyrosine Kinases - genetics | Cell Differentiation - drug effects | Intercellular Signaling Peptides and Proteins - pharmacology | Signal Transduction - physiology | Cell Proliferation - drug effects | Mice | Arthritis, Experimental - enzymology | Osteoclasts - drug effects | Tyrosine | Complications and side effects | Hyperplasia | Influence | Arthritis | Genetic aspects | Risk factors | Disease | Cytokines | Psoriasis | Inflammation | Kinases | Studies | MicroRNAs | Fibroblasts | Bones | Ligands | Tumor necrosis factor-TNF | Growth factors
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 640 - 640
Abstract Introduction: In chronic lymphocytic leukemia (CLL), improved anti-CD20 antibodies such as obinutuzumab (GA101) and targeted drugs, such as ibrutinib,... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4151 - 4151
Abstract Introduction: In chronic lymphocytic leukemia (CLL) treatment with anti-CD20 antibodies including obinutuzumab (GA101) and targeted drugs, such as... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3327 - 3327
Abstract Introduction: Chemoimmunotherapy with the glycoengineered type II anti-CD20 antibody obinutuzumab plus the alkylating drug chlorambucil (G-Clb... 
Journal Article
by Streng, Andrea and Prifert, Christiane and Weissbrich, Benedikt and Liese, Johannes G and Bösel, Nadja and Gašpirová, Petra and Henrich, Katharina and Hösl, Angela and Klein, Maximilian and Schnelke, Alexander and Wieg, Christian and Steinherr, Harry and Schreiner, Hans-Georg and Horsinka, Sibylle and Wolf, Alfons and Engelke, Engelke and Pohl, Wolfgang and Bohlein, Barbara and Egler, Kerstin and Glas, Katharina and Iven, Annegret and Leistner, Christiane and Lippert, Lena and Kothari, Radhika and Panagiota, Chaitidou and Rettner, Daniela and Thomaschewski, S and Weigelt, Annika and Wenzel, Beatrix and Zapf, Florian and Stuber, Gerlinde and Schroth, Michael and Topf, Hans-Georg and Steigenberger, Herbert and Maksutova, Maksutova and Ponader, Rolf and Götz, Oliver and Eberhardt, Heinrich and Quitterer, Andrea and Aleo, Angelo and Bischof, A and Brenner, B and Brunnhölzl, Wolfgang and Doll, Ulrike and Hagemann, Sonja and Pauker, S and Pfadler, Eva and Schmidt, Ann-Kathrin and Schuler, Rahel and Stange, T and Steidl, Michael and Hoffmann, Florian and Behrends, Uta and Berndt, J and Damke, Lilian and Demir, Iffet and Dreßel, Petra and Gallitz, Stephanie and Heck, Bambul and Jünger, Hendrik and Mahmoud, Mahmoud and Sassen, Uwe and Wagner, Claudia and Hammersen, Gerhard and Göhl, Nathalie and Jansen, Verena and Schmidtlein, Christoph and Munser, Stefan and Schmidt, D and Adolphs, Christian and Keinath, Susanne and Ritz, Christina and Röding, Stefanie and Schweiß, Isabel and Trips, Tobias and Adam, Klaus and Baumann, Anja and Moser, Andrea and Sperber, K and Thomas, Wolfgang and Wirbelauer, Johannes and Kunzmann, Steffen and Doerck, Manfred and Kitz, Christa and Borgmann, Kristina and Grombach, Jens and Bavarian PICU Study Grp Influenza and Bavarian PICU Study Group on Influenza and Other Viral ARI and for the Bavarian PICU Study Group on Influenza and Other Viral ARI
BMC Infectious Diseases, ISSN 1471-2334, 12/2015, Volume 15, Issue 1, p. 573